In two studies [17,19], a galectin-3 threshold value of 17.8 ng/ml was applied, based on the U.S. Food and Drug Administration—cleared assay labeling of galectin for risk stratification in patients with HF [29]. The gene discussed is LGALS3; the disease is hydrops fetalis.